This study identified that cell models of JAK2r ALL can develop JAK inhibitor resistance via acquisition of mutations within JAK2 ATP-binding site following long-term exposure to JAK inhibitors. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.